Similarly, studies in bladder cancer show that ANLN knockdown triggers G2/M arrest and decreases Cyclin B1 and Cyclin D1 expression, thereby suppressing tumor growth (Zeng et al., 2017). Here, ANLN is linked to urinary bladder cancer.